Avian/Pandemic Influenza Registry (AVEX Registry)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/2865
• EU PAS number:
  EUPAS2113
• Study ID:
  2865
• Official title and acronym:
  Avian/Pandemic Influenza Registry (AVEX Registry)
• DARWIN EU® study:
  No
• Study countries:
  Azerbaijan

  Bangladesh

  Cambodia

  China

  Egypt

  Hong Kong

  Indonesia

  Lao People's Democratic Republic

  Nigeria

  Pakistan

  Thailand

  Türkiye

  Viet Nam
• Study description:
  This is an observational patient registry of humans infected with avian influenza A (H5N1). The registry is a collaborative study involving members of the international scientific, medical and public health communities. The registry collects information from many countries on patients' exposures, symptoms, presentation for medical care, virologic testing, treatment, clinical course and survival in order to better understand the clinical course and effectiveness of current treatments for H5N1 infections in humans.
• Study status:
  Finalised

Research institutions and networks

Institutions

Scientific Affairs, Outcome SARL

Switzerland

Multiple centres: 9 centres involved in this study across 9 countries, list available on request

Networks

Full list available on request

Study timelines

Date when funding contract was signed

Planned: 01/01/2007

Actual: 12/12/2006

Study start date

Planned: 03/04/2007

Actual: 26/03/2007

Data analysis start date

Planned: 16/10/2007

Actual: 16/10/2007

Date of interim report, if expected

Planned: 15/07/2011

Actual: 18/07/2011

Date of final study report

Planned: 30/06/2012

Actual: 20/06/2012

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

F. Hoffmann-La Roche Ltd

Study protocol

Initial protocol

Avian-Pandemic Influenza Registry_Revised Protocol_16Oct08Final

Regulatory

• Was the study required by a regulatory body?:
  No